BARD1 Competitors and Similar CompaniesClear all
BARD1's competitors and similar companies include Vivacitas Oncology, Cardiff Oncology, Cellis and MiRXES.
 BARD1 BARD1 Life Sciences is a company focused on developing and commercializing non-invasive diagnostic tests for early detection of cancer. |  Vivacitas Oncology Vivacitas Oncology is a company developing approaches for cancers resistant to standard treatment modalities. |  Cellis Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology. | |||
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 1999 | Founding Date 2015 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Notting Hill, AU HQ | Locations Walnut Creek, US HQ | Locations San Diego, US HQ | Locations Zürich, CH HQ Warsaw, PL | Locations Singapore, SG HQ Hangzhou, CN Tianjin, CN Hong Kong, HK Tokyo, JP Singapore, SG Singapore, SG see more |
Employees | Employees 5 | Employees 6 | Employees 14 | Employees 23 | Employees 1451% decrease |
Valuation ($) | Valuation ($) 62.9 m | Valuation ($) N/A | Valuation ($) 145.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $547k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $593k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($6.9m) (FY, 2025) | Net income N/A | Net income ($45.9m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 50.5m | Total funding raised N/A | Total funding raised $ 81m |
For sources of this data, please see the company profile
View Company Profiles
Vivacitas Oncology
HQ
Walnut Creek, US
Employees
6
Vivacitas Oncology is a company developing approaches for cancers resistant to standard treatment modalities.
View companyCellis
HQ
Zürich, CH
Employees
23
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
View company
MiRXES
HQ
Singapore, SG
Employees
145↓ 1% decrease
MiRXES is a biotech company focused on microRNA research and applications.
View company